|
Factor | Wnt5a expression level | Wnt5a function | Mechanism | CRC sample type | Reference |
|
Methylation | Low | Tumor suppressor | Stimulation of tumor cell clonogenicity by upregulation of β-catenin and overactivation of Wnt β-catenin signaling | CRC cell lines | [44] |
Ectopic model | High | Tumor suppressor | Inhibition of cell proliferation and metastasis via suppression of EMT, Wnt canonical, and overactivation of Wnt/Ca2+ signaling | HCT116 | [45] |
Unmethylation | High | Tumor suppressor | Increasing inhibitory effect of 5-FU | LoVo, SW480, HCT116, and SW620 | [46] |
Vitamin D intake | High | Tumor suppressor | Inhibition of cell proliferation through enhancing levels of Wnt5a methylation | Tissue | [47] |
Genistein | High | Tumor suppressor | Suppression of cell proliferation via reducing levels of CpG island methylation of Wnt5a | SW1116 | [48] |
Trichostatin A (TSA)/sodium butyrate (NaBt) | High | Tumor suppressor | Stimulation of levels of Wnt5a expression by decreasing acetylation levels of histones including H3Ac, H4Ac, and H3K4me2 | SW620 and SW480 | [49] |
EZH2 | Low | Tumor suppressor | Enhancing cell proliferation via hypermethylation of Wnt5a promotes H3K27 and overactivation of TGF-β signaling | SW480 | [50] |
Recombinant Wnt5a (rWnt5a)/Foxy-5 | High | Tumor suppressor | Inhibition of cell proliferation and stimulation of cell differentiation by overexpression of 15-PGDH and inactivation of Wnt β-catenin | HT-29 and Caco-2 | [51] |
CaSR | High | Tumor suppressor | Suppression of cell proliferation via inactivation of Wnt β-catenin and overexpression of Ror2 and Siah-2 | HT-29 | [52] |
LPS | High | Tumor suppressor | Reduction of TNF-α-induced Wnt3a signaling via decreasing expression levels of TNFR1 and increasing CaSR and Ror2 | CaSR-HEK, RAW264.7, and HT-29 | [53] |
miR-567-5p | Low | Tumor suppressor | Stimulation of cell proliferation by upregulation of β-catenin and downregulation of Wnt5a | SW480 | [55] |
pcDNA-Wnt5a/XAV939 inhibitor | High | Tumor suppressor | Inhibition of cell viability, migration, and invasion through suppression of miR-567-5p activity and inactivation of Wnt β-catenin signaling | SW480 | [55] |
miR-26b | Low | Tumor suppressor | Stimulation of CRC cells metastasis via enhancing EMT and downregulation of Wnt5a and PTEN | Caco-2, DLD1 | [56] |
Methylation | Low | Tumor suppressor | Increasing MSI tumors features | Tissue | [57] |
DNMT1 | Low | Tumor suppressor | Enhancing tumor stage | Tissue | [58] |
|